Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
A
|
Advanced Micro Devices Inc
SWB:AMD
|
US |
|
Loblaw Companies Ltd
TSX:L
|
CA |
|
Preferred Bank
NASDAQ:PFBC
|
US |
Wall St Price Targets
REGN Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for REGN is 847.04 USD with a low forecast of 647.41 USD and a high forecast of 1 050 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is REGN's stock price target?
Price Target
847.04
USD
According to Wall Street analysts, the average 1-year price target for REGN is 847.04 USD with a low forecast of 647.41 USD and a high forecast of 1 050 USD.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
23%
The compound annual growth rate for Operating Income over the next 3 years is 23%.
What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 15%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Net Income over the next 3 years is 15%.
